Phase I study of delivery of autologous bone marrow derived mononuclear cells to myopathic right ventricle in patients with Ebstein anomaly during surgical intervention
Grant Project Details:
Awardee:
Kimberly Holst, MD
Timeframe:
2016-2018
Location:
Mayo Clinic | Rochester, MN
Amount:
$500,000
Status:
In Process
Explore all RMM grants awarded since inception
Grant timeline: proposal, updates, reports
Grant Description
The goal of this Phase I study is to establish the safety and feasibility of intramyocardial injection of autologous bone marrow derived mononuclear cells (BM-MNC) into the myopathic right ventricle of patients with Ebstein anomaly (EA) at time of elective cardiac surgery.
In no-cost extension to enroll additional patients in study
Grant Awardee Biography
Dr. Holst is a general and thoracic surgery resident at Mayo Clinic and a resident in the Clinician Investigator Training Program.